INTERNATIONAL PATENT: CELCUITY INC. FILES APPLICATION FOR "TREATMENT REGIMENS FOR GEDATOLISIB IN HORMONALLY-DRIVEN DISORDERS"

GENEVA, March 4 -- CELCUITY INC. (16305 36th Ave N. Ste 100Minneapolis, MN 55446) filed a patent application (PCT/US2025/042990) for "TREATMENT REGIMENS FOR GEDATOLISIB IN HORMONALLY-DRIVEN DISORDERS" on Aug 21, 2025. With publication no. WO/2026/044119, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SULLIVAN, Brian, Francis (16305 36th Ave N. Ste 100Minneapolis, MN 55446), LAING, Lance, Gavin (16305 36th Ave N. Ste 100Minneapolis, MN 55446)

Abstract: Methods for treating hormonally driven disorders by administering the...